home / stock / cogt / cogt news


COGT News and Press, Cogent Biosciences Inc Com From 02/14/24

Stock Information

Company Name: Cogent Biosciences Inc Com
Stock Symbol: COGT
Market: NASDAQ
Website: cogentbio.com

Menu

COGT COGT Quote COGT Short COGT News COGT Articles COGT Message Board
Get COGT Alerts

News, Short Squeeze, Breakout and More Instantly...

COGT - DTSS, TNON and BREA among mid-day movers

2024-02-14 13:54:31 ET More on Mid-day movers & stocks. Financial information for Brera Holdings PLC Financial information for Datasea Seeking Alpha’s Quant Rating on Tenon Medical Historical earnings data for Tenon Medical Financial inform...

COGT - Cogent Biosciences Inc. (NASDAQ: COGT) Leading the Way in Wednesday Trading Based on Percentage Gain

Cogent Biosciences, Inc. (NASDAQ: COGT) is one of today's top gainers. The company's shares have moved 60.44% on the day to $8.76. Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes ...

COGT - Cogent Biosciences Reports Oversubscribed $225M PP

2024-02-14 09:31:30 ET DENVER, Colo., Feb. 14, 2024 ( www.247marketnews.com )- Cogent Biosciences, Inc.  (NASDAQ: COGT ) reported, this morning, that it entered into a securities purchase agreement for a private investment in public equity financing in which Cogent will sell ...

COGT - Cogent Biosciences announces oversubscribed $225M private placement

2024-02-14 09:16:40 ET More on Cogent Biosciences Citi starts Cogent Biosciences at buy, cites GI tumor drug potential AIM stock dips amid mixed results for post-COVID fatigue therapy Seeking Alpha’s Quant Rating on Cogent Biosciences Historical earnin...

COGT - Cogent Biosciences Announces Oversubscribed $225 Million Private Placement

Pro-forma cash, cash equivalents and marketable securities expected to fund the Company into 2027 and through clinical readouts from ongoing SUMMIT, PEAK and APEX registration-directed trials Cogent to host investor webcast at 8:00 a.m. ET on February 23 to review the SUMMIT P...

COGT - Citi starts Cogent Biosciences at buy, cites GI tumor drug potential

2024-02-08 14:11:11 ET More on Cogent Biosciences AIM stock dips amid mixed results for post-COVID fatigue therapy Cogent Biosciences issues study updates on bezuclastinib, CGT4859 Seeking Alpha’s Quant Rating on Cogent Biosciences Historical earnings ...

COGT - AIM stock dips amid mixed results for post-COVID fatigue therapy

2024-02-08 11:37:46 ET More on Agios Pharmaceuticals, AIM ImmunoTech, etc. CVS Health Corporation (CVS) Q4 2023 Earnings Call Transcript CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance CVS Health Corporation 2023 Q4 - Results - Earni...

COGT - Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meeting

WALTHAM, Mass. and BOULDER, Colo., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its upcoming posters for bezuclastinib at the 2024 American Aca...

COGT - CHEA, LESL and NUBI are among after hour movers

2024-02-02 17:07:29 ET Gainers: Chenghe Acquisition ( CHEA ) +58% . Leslie's ( LESL ) +6% . Office Properties Income Trust ( OPI ) +4% . Tactile Systems Technology ( TCMD ) +4% . Big 5 Sporting Goods ( BGFV ) +3% . Losers: ...

COGT - How to Take Advantage of moves in (COGT)

2024-01-14 09:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10